Deferasiroks Pliva 125 mg tablete za oralnu suspenziju
| Name | Deferasiroks Pliva 125 mg tablete za oralnu suspenziju |
|---|---|
| Marketing Authorisation Number | HR-H-522308269 |
| Active Substance | deferasiroks |
| Composition | svaka tableta za oralnu suspenziju sadrži 125 mg deferasiroksa |
| Pharmaceutical Form | tableta za oralnu suspenziju |
| Packaging [MA Number for Packaging] | 28 tableta u blisteru, u kutiji [HR-H-522308269-01] 28 tableta u blisteru s jediničnom dozom, u kutiji [HR-H-522308269-02] 30 tableta u blisteru, u kutiji [HR-H-522308269-03] 30 tableta u blisteru s jediničnom dozom, u kutiji [HR-H-522308269-04] 84 tablete u blisteru, u kutiji [HR-H-522308269-05] 84 tableta u blisteru s jediničnom dozom, u kutiji [HR-H-522308269-06] 98 tableta u blisteru, u kutiji [HR-H-522308269-07] 98 tableta u blisteru s jediničnom dozom, u kutiji [HR-H-522308269-08] |
| Manufacturer | Merckle GmbH, Blaubeuren, Njemačka Pliva Hrvatska d.o.o., Zagreb, Hrvatska |
| Marketing Authorisation Holder | Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, Hrvatska |
| Marketing Authorisation Date | 07.04.2022 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/21-02/195 |
| Registration Number | 381-12-01/154-22-03 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | V03AC03 |
| Medicinal product marketed in the Croatia | Ne |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Educational materials for healthcare professionals |
Vodič za zdravstvene radnike, verzija 2 |
| Educational materials for patients / caregivers |
Vodič za bolesnike, verzija 2 |
